Latest Food & Drug Administration news
Outpatient Gabapentin Rarely Used for Approved Indications
posted November 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Both Pfizer, Moderna Boosters for All Adults
posted November 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Virtual Reality System to Ease Back Pain
posted November 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pfizer Asks FDA for Emergency Approval of Its COVID-19 Antiviral Pill
posted November 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
FDA Now Providing Daily Updates on Adverse Events 
FDA Suspends U.S. License of Chikungunya Vaccine 
FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products 
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods Monthly Specialist Briefings
Stay Connected
